The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Alimera Sciences, Inc | COM | 016259103 | 257 | 184,827 | SH | SOLE | 184,827 | 0 | 0 | ||
| Alere Inc. | COM | 01449J105 | 5,019 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| Amarin Corp PLC - SPONS ADR | SPONS ADR | 023111206 | 302 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| Avadel Pharmaceuticals PLC | SPONS ADR | 05337M104 | 8,249 | 747,863 | SH | SOLE | 747,863 | 0 | 0 | ||
| Biodelivery Sciences INTL | COM | 09060J106 | 9,737 | 3,477,673 | SH | SOLE | 3,477,673 | 0 | 0 | ||
| Biospecifics Technologies Co. | COM | 090931106 | 2,965 | 59,878 | SH | SOLE | 59,878 | 0 | 0 | ||
| CAS Medical Systems Inc | COM PAR | 124769209 | 1,044 | 900,366 | SH | SOLE | 900,366 | 0 | 0 | ||
| CAREDX, Inc. | COM | 14167L103 | 212 | 190,909 | SH | SOLE | 190,909 | 0 | 0 | ||
| Corium International, Inc. | COM | 21887L107 | 3,085 | 413,568 | SH | SOLE | 413,568 | 0 | 0 | ||
| Cumberland Pharmaceuticals, Inc. | COM | 230770109 | 7,764 | 1,109,167 | SH | SOLE | 1,109,167 | 0 | 0 | ||
| Cardiome Pharma Corp | COM | 14159U301 | 7,212 | 1,595,549 | SH | SOLE | 1,595,549 | 0 | 0 | ||
| CTI Biopharmap Corp. | COM | 12648L601 | 7,561 | 2,284,381 | SH | SOLE | 2,284,381 | 0 | 0 | ||
| Cutera Inc. | COM | 232109108 | 4,533 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| Depomed Inc. | COM | 249908104 | 1,360 | 126,600 | SH | SOLE | 126,600 | 0 | 0 | ||
| Durect Corporation | COM | 266605104 | 4,955 | 3,175,994 | SH | SOLE | 3,175,994 | 0 | 0 | ||
| Enanta Pharmaceuticals | COM | 29251M106 | 17,712 | 492,265 | SH | SOLE | 492,265 | 0 | 0 | ||
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 13 | 2,878 | SH | SOLE | 2,878 | 0 | 0 | ||
| Neos Therapeutics, Inc. | COM | 64052L106 | 4,125 | 565,100 | SH | SOLE | 565,100 | 0 | 0 | ||
| Novelion Therapeutics, Inc. | COM | 67001K202 | 17,098 | 1,852,395 | SH | SOLE | 1,852,395 | 0 | 0 | ||
| Ophthotech Corp | COM | 683745103 | 9,155 | 3,576,189 | SH | SOLE | 3,576,189 | 0 | 0 | ||
| Recro Pharma, Inc. | COM | 75629F109 | 12,863 | 1,829,669 | SH | SOLE | 1,829,669 | 0 | 0 | ||
| Sciclone Pharmaceuticals, Inc. | COM | 80862K104 | 2,379 | 216,307 | SH | SOLE | 216,307 | 0 | 0 | ||
| Trinity Biotech PLC - SPON ADR | SPONS ADR | 896438306 | 1,872 | 311,994 | SH | SOLE | 311,994 | 0 | 0 | ||
| Vericel Corp | COM | 92346J108 | 9,836 | 2,980,570 | SH | SOLE | 2,980,570 | 0 | 0 | ||
| Veracyte, Inc. | COM | 92337F107 | 7,203 | 864,695 | SH | SOLE | 864,695 | 0 | 0 | ||
| Viveve Medical, Inc | COM | 92852W204 | 27,513 | 3,849,711 | SH | SOLE | 3,849,711 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 11,167 | 685,086 | SH | SOLE | 685,086 | 0 | 0 | ||